These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Takahashi T; Kalka C; Masuda H; Chen D; Silver M; Kearney M; Magner M; Isner JM; Asahara T Nat Med; 1999 Apr; 5(4):434-8. PubMed ID: 10202935 [TBL] [Abstract][Full Text] [Related]
12. [Arteriogenesis: a new strategy of therapeutic intervention in chronic arterial disorders. Cellular mechanism and experimental models]. Erdo F; Buschmann IR Orv Hetil; 2007 Apr; 148(14):633-42. PubMed ID: 17403636 [TBL] [Abstract][Full Text] [Related]
13. Polydeoxyribonucleotide (PDRN): a safe approach to induce therapeutic angiogenesis in peripheral artery occlusive disease and in diabetic foot ulcers. Altavilla D; Bitto A; Polito F; Marini H; Minutoli L; Di Stefano V; Irrera N; Cattarini G; Squadrito F Cardiovasc Hematol Agents Med Chem; 2009 Oct; 7(4):313-21. PubMed ID: 19860658 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic angiogenesis. Isner JM; Takayuki A Front Biosci; 1998 May; 3():e49-69. PubMed ID: 9567005 [TBL] [Abstract][Full Text] [Related]
15. [The molecular bypass: an established method for revascularisation of non-operable PAD patients or merely a future vision]. Herold J; Said S; Braun-Dullaeus R Zentralbl Chir; 2014 Oct; 139(5):508-17. PubMed ID: 24089345 [TBL] [Abstract][Full Text] [Related]
16. [Enhancement of angiogenesis as the basis of reparative morphogenesis in ischemic myocardial lesion]. Potapov IV; Kirillov IA Vestn Ross Akad Med Nauk; 2007; (9):3-9. PubMed ID: 18030711 [TBL] [Abstract][Full Text] [Related]
17. Gene therapy for myocardial angiogenesis. Losordo DW; Vale PR; Isner JM Am Heart J; 1999 Aug; 138(2 Pt 2):S132-41. PubMed ID: 10426872 [TBL] [Abstract][Full Text] [Related]
18. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275 [TBL] [Abstract][Full Text] [Related]
19. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization. Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531 [TBL] [Abstract][Full Text] [Related]
20. Angiogenesis--a new goal in peripheral artery occlusive disease therapy. Mäkinen K Acta Chir Belg; 2003 Oct; 103(5):470-4. PubMed ID: 14653030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]